Shaping health policy in Japan can be difficult for Western corporations who are used to bold actions and autonomous decision-making rather than the incremental and consensus-based style favoured in the country. Here, we look at the three essential components to success.

Several countries in Europe have begun to put in place national pharmaceutical policies as they vie for a dominant position in this economically significant industry. A new report looks into the similarities and differences between approaches in the UK, France and Germany – a welcome lesson for other countries.